Samuel M Behar Selected Research

Samuel M Behar Research Topics

Disease

34	Tuberculosis (Tuberculoses) 06/2022 - 11/2002
31	Infections 06/2022 - 07/2003
5	Necrosis 01/2013 - 11/2008
4	Granuloma 10/2022 - 05/2015
3	Inflammation (Inflammations) 02/2014 - 10/2010
2	Persistent Infection 03/2016 - 05/2015
2	Latent Tuberculosis 03/2009 - 09/2008
1	Atrophy 01/2021
1	Hyperglycemia 11/2014
1	Starvation 12/2013
1	Pulmonary Tuberculosis 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Pneumonia (Pneumonitis) 10/2011
1	Genital Diseases 05/2011
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 08/2010
1	Rheumatoid Arthritis 03/2010
1	Rheumatic Diseases (Rheumatism) 03/2009
1	Lyme Disease (Disease, Lyme) 09/2006
1	Neoplasms (Cancer) 11/2003
1	Communicable Diseases (Infectious Diseases) 11/2002
1	Autoimmune Diseases (Autoimmune Disease) 06/2002

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 10/2022 - 09/2005
11	AntigensIBA 01/2020 - 12/2004
9	CytokinesIBA 01/2021 - 12/2008
8	LipidsIBA 01/2016 - 11/2003
6	AerosolsIBA 02/2016 - 11/2008
4	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 09/2008
4	InterferonsIBA 01/2021 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2002
3	Peptides (Polypeptides)IBA 01/2020 - 09/2005
3	EpitopesIBA 01/2020 - 12/2004
3	EicosanoidsIBA 01/2016 - 01/2010
3	ProstaglandinsIBA 08/2010 - 11/2008
3	Prostaglandins EIBA 01/2010 - 11/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2020
2	Interleukin-2 (IL2)IBA 01/2021 - 03/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017 - 01/2014
2	lipoxin A4IBA 01/2013 - 11/2008
2	Dinoprostone (PGE2)FDA Link 01/2013 - 11/2008
2	LigandsIBA 10/2010 - 11/2002
2	alpha-galactosylceramideIBA 09/2010 - 11/2002
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Recombinant ProteinsIBA 01/2020
1	PPAR gammaIBA 10/2017
1	Neutralizing AntibodiesIBA 10/2017
1	interleukin-21 (interleukin 21)IBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Interleukin-10 (Interleukin 10)IBA 03/2016
1	Interleukin-27 (Interleukin 27)IBA 02/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2016
1	Interleukin-12 (IL 12)IBA 02/2016
1	ProteomeIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	BCG Vaccine FDA Link 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2015
1	Immunodominant EpitopesIBA 05/2015
1	p38 Mitogen-Activated Protein KinasesIBA 11/2014
1	ChromatinIBA 11/2014
1	Receptor for Advanced Glycation End ProductsIBA 11/2014
1	Tryptophan (L-Tryptophan)FDA Link 12/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	invariant chain (Ii-Key)IBA 08/2011
1	Lysosomal Membrane ProteinsIBA 08/2011
1	Carrier Proteins (Binding Protein)IBA 05/2011
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	Viral VaccinesIBA 05/2011
1	Galactosylceramides (Galactocerebrosides)IBA 09/2010
1	microsomal triglyceride transfer proteinIBA 08/2010
1	LipoxinsIBA 08/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	Tumor Necrosis Factor InhibitorsIBA 03/2009
1	PerforinIBA 12/2008
1	Prostaglandin-E SynthasesIBA 11/2008
1	Biological ProductsIBA 10/2008
1	SolutionsIBA 09/2008
1	GoldIBA 09/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2006
1	DiglyceridesIBA 09/2006
1	GlycosphingolipidsIBA 09/2006
1	GlycolipidsIBA 09/2006
1	IntegrinsIBA 04/2006
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2006
1	Cell ExtractsIBA 11/2003
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2003

Therapy/Procedure

3	Therapeutics 06/2022 - 11/2002
1	Lasers (Laser) 01/2016
1	Immunotherapy 10/2008